Article
How Important Are Skyrizi and Rinvoq to AbbVie's Q1 Results?
Strong Bullish
88.6
−100 Bearish
0
+100 Bullish
ABBV's Q1 beat is powered by Skyrizi and Rinvoq, whose strong sales growth offset Humira declines and boosts 2026 guidance.
Actions
Pulse AI
Pulse analysis not available yet. Click "Get Pulse" above.
Generated by Pulse AI, Glideslope's proprietary engine for interpreting market sentiment and economic signals. For informational purposes only — not financial advice.
Article Info
Source
finance.yahoo.com
Published
May 15, 2026 · 10:59 am
Article ID
T217XML
Original URL
Open source
Sentiment Signal
Strong Bullish
88.6
−100Neutral+100
More Like This